Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
Sinovac Biotech Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | -6.636B |
April 24, 2024 | -6.636B |
April 23, 2024 | -6.636B |
April 22, 2024 | -6.636B |
April 19, 2024 | -6.636B |
April 18, 2024 | -6.636B |
April 17, 2024 | -6.636B |
April 16, 2024 | -6.636B |
April 15, 2024 | -6.636B |
April 12, 2024 | -6.636B |
April 11, 2024 | -6.636B |
April 10, 2024 | -6.636B |
April 09, 2024 | -6.636B |
April 08, 2024 | -6.636B |
April 05, 2024 | -6.636B |
April 04, 2024 | -6.636B |
April 03, 2024 | -6.636B |
April 02, 2024 | -6.636B |
April 01, 2024 | -6.636B |
March 28, 2024 | -6.636B |
March 27, 2024 | -6.636B |
March 26, 2024 | -6.636B |
March 25, 2024 | -6.636B |
March 22, 2024 | -6.636B |
March 21, 2024 | -6.636B |
Date | Value |
---|---|
March 20, 2024 | -6.636B |
March 19, 2024 | -6.636B |
March 18, 2024 | -6.636B |
March 15, 2024 | -6.636B |
March 14, 2024 | -6.636B |
March 13, 2024 | -6.636B |
March 12, 2024 | -6.636B |
March 11, 2024 | -6.636B |
March 08, 2024 | -6.636B |
March 07, 2024 | -6.636B |
March 06, 2024 | -6.636B |
March 05, 2024 | -6.636B |
March 04, 2024 | -6.636B |
March 01, 2024 | -6.636B |
February 29, 2024 | -6.636B |
February 28, 2024 | -6.636B |
February 27, 2024 | -6.636B |
February 26, 2024 | -6.636B |
February 23, 2024 | -6.636B |
February 22, 2024 | -6.636B |
February 21, 2024 | -6.636B |
February 20, 2024 | -6.636B |
February 16, 2024 | -6.636B |
February 15, 2024 | -6.636B |
February 14, 2024 | -6.636B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.861B
Minimum
Jan 03 2023
-6.558B
Maximum
Nov 01 2022
-6.702B
Average
-6.636B
Median
Jun 30 2023
Enterprise Value Benchmarks
CASI Pharmaceuticals Inc | 18.95M |
Zai Lab Ltd | 755.09M |
I-MAB | -- |
Gracell Biotechnologies Inc (DELISTED) | -- |
Adagene Inc | 15.77M |